Fingerprint
Dive into the research topics of 'Luspatercept in patients with lower-risk myelodysplastic syndromes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Luspatercept in patients with lower-risk myelodysplastic syndromes
Pierre Fenaux*, Uwe Platzbecker, Ghulam J. Mufti, Guillermo Garcia-Manero, Rena Buckstein, Valeria Santini, María Díez-Campelo, Carlo Finelli, Mario Cazzola, Osman Ilhan, Mikkael A. Sekeres, José F. Falantes, Beatriz Arrizabalaga, Flavia Salvi, Valentina Giai, Paresh Vyas, David Bowen, Dominik Selleslag, Amy E. DeZern, Joseph G. Jurcic
*Corresponding author for this work
- University of Paris VII - Denis Diderot University
- University Hospital Leipzig
- University of Texas M. D. Anderson Cancer Center
- Odette Cancer Centre
- Careggi Hospital
- Hospital Universitario de Salamanca
- Alma Mater Studiorum Universita di Bologna
- University of Pavia
- Faculty of Medicine
- Cleveland Clinic Foundation
- Hosp Univ Virgen del Rocio, Hospital Universitario Virgen del Rocio, Hospital Universitario Virgen del Rocio
- Universidad Del Pais Vasco (UPV/EHU)
- Santi Antonio e Biagio e Cesare Arrigo Hospital
- Leeds Teaching Hospitals NHS Trust
- Algemeen Ziekenhuis Sint-Jan
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Columbia University
- University Hospital
- Helmholtz Center Munich
- Centre Hospitalo Universitaire De Lille
- CHU Toulouse, CHU de Toulouse, Dept Med Genet
- Université Côte d'Azur
- Policlinico Universitario Tor Vergata Clinica Dermatologica
- Ghent University Hospital
- University Medical Center Groningen
- Stanford University
- Karolinska Institute
- Yale University
- Yeshiva University
- Vanderbilt University School of Medicine
- Celgene Corporation
- Celgene International Sàrl
- Acceleron Pharma
- H. Lee Moffitt Cancer Center and Research Institute
- University of Oxford
Research output: Contribution to journal › Article › peer-review
376
Citations
(Scopus)